Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $0.46 in the prior trading day, Theriva Biologics Inc (AMEX: TOVX) closed at $0.44, down -4.97%. In other words, the price has decreased by -$4.97 from its previous closing price. On the day, 1.44 million shares were traded. TOVX stock price reached its highest trading level at $0.45 during the session, while it also had its lowest trading level at $0.417.
Ratios:
Our goal is to gain a better understanding of TOVX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.19 and its Current Ratio is at 1.19. In the meantime, Its Debt-to-Equity ratio is 0.27 whereas as Long-Term Debt/Eq ratio is at 0.21.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TOVX now has a Market Capitalization of 4223098 and an Enterprise Value of -5005901.
Stock Price History:
The Beta on a monthly basis for TOVX is 0.73, which has changed by -0.8646154 over the last 52 weeks, in comparison to a change of 0.15222645 over the same period for the S&P500. Over the past 52 weeks, TOVX has reached a high of $7.15, while it has fallen to a 52-week low of $0.37. The 50-Day Moving Average of the stock is -3.27%, while the 200-Day Moving Average is calculated to be -58.70%.
Shares Statistics:
The stock has traded on average 909.40K shares per day over the past 3-months and 1561100 shares per day over the last 10 days, according to various share statistics. A total of 9.60M shares are outstanding, with a floating share count of 9.50M. Insiders hold about 1.04% of the company’s shares, while institutions hold 7.94% stake in the company. Shares short for TOVX as of 1753920000 were 91623 with a Short Ratio of 0.10, compared to 1751241600 on 95184. Therefore, it implies a Short% of Shares Outstanding of 91623 and a Short% of Float of 1.01.
Earnings Estimates
Theriva Biologics Inc (TOVX) is presently subject to a detailed evaluation by 1.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.37, with high estimates of -$0.37 and low estimates of -$0.37.
Analysts are recommending an EPS of between -$2.15 and -$2.15 for the fiscal current year, implying an average EPS of -$2.15. EPS for the following year is -$0.75, with 1.0 analysts recommending between -$0.75 and -$0.75.
